Copyright Reports & Markets. All rights reserved.

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Type
    • 1.3.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Carbon-14
    • 1.3.4 Technetium-99m
    • 1.3.5 Iodine-131
    • 1.3.6 Iodine-125
    • 1.3.7 Others
  • 1.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market by Application
    • 1.4.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Nuclear Medicine Diagnosis
    • 1.4.3 Nuclear Medicine Treatment
    • 1.4.4 Others
  • 1.5 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size & Forecast
  • 1.6 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast by Region
    • 1.6.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 NRG
    • 2.1.1 NRG Details
    • 2.1.2 NRG Major Business
    • 2.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.1.4 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NRG Recent Developments and Future Plans
  • 2.2 NTP Radioisotopes
    • 2.2.1 NTP Radioisotopes Details
    • 2.2.2 NTP Radioisotopes Major Business
    • 2.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.2.4 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 NTP Radioisotopes Recent Developments and Future Plans
  • 2.3 JSC Isotope
    • 2.3.1 JSC Isotope Details
    • 2.3.2 JSC Isotope Major Business
    • 2.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.3.4 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 JSC Isotope Recent Developments and Future Plans
  • 2.4 ANSTO
    • 2.4.1 ANSTO Details
    • 2.4.2 ANSTO Major Business
    • 2.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.4.4 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ANSTO Recent Developments and Future Plans
  • 2.5 China National Nuclear Corporation (CNNC)
    • 2.5.1 China National Nuclear Corporation (CNNC) Details
    • 2.5.2 China National Nuclear Corporation (CNNC) Major Business
    • 2.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.5.4 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
  • 2.6 IRE ELIT
    • 2.6.1 IRE ELIT Details
    • 2.6.2 IRE ELIT Major Business
    • 2.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.6.4 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 IRE ELIT Recent Developments and Future Plans
  • 2.7 Nordion
    • 2.7.1 Nordion Details
    • 2.7.2 Nordion Major Business
    • 2.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.7.4 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nordion Recent Developments and Future Plans
  • 2.8 Polatom
    • 2.8.1 Polatom Details
    • 2.8.2 Polatom Major Business
    • 2.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
    • 2.8.4 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Polatom Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Company Revenue
    • 3.2.2 Top 3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
  • 3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Region Footprint
    • 3.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Type Footprint
    • 3.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2021-2032)
  • 6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
    • 6.3.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
  • 7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
    • 7.3.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
  • 9.3 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
    • 9.3.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
  • 11.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
  • 11.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Chain
  • 12.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Upstream Analysis
  • 12.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Midstream Analysis
  • 12.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Radioisotopes for Nuclear Medicine Diagnosis and Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Radioisotopes for Nuclear Medicine Diagnosis and Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Carbon-14
    Technetium-99m
    Iodine-131
    Iodine-125
    Others
    Market segment by Application
    Nuclear Medicine Diagnosis
    Nuclear Medicine Treatment
    Others
    Market segment by players, this report covers
    NRG
    NTP Radioisotopes
    JSC Isotope
    ANSTO
    China National Nuclear Corporation (CNNC)
    IRE ELIT
    Nordion
    Polatom
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Radioisotopes for Nuclear Medicine Diagnosis and Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, with revenue, gross margin, and global market share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment from 2021 to 2026.
    Chapter 3, the Radioisotopes for Nuclear Medicine Diagnosis and Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radioisotopes for Nuclear Medicine Diagnosis and Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Radioisotopes for Nuclear Medicine Diagnosis and Treatment.
    Chapter 13, to describe Radioisotopes for Nuclear Medicine Diagnosis and Treatment research findings and conclusion.

    Buy now